| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,648 |
8,070 |
$718K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,547 |
2,880 |
$323K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,340 |
1,278 |
$123K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,248 |
6,351 |
$104K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,006 |
1,898 |
$88K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
900 |
841 |
$79K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
743 |
723 |
$73K |
| 99215 |
Prolong outpt/office vis |
492 |
399 |
$60K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,936 |
1,390 |
$46K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
630 |
500 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
949 |
829 |
$16K |
| 92283 |
|
1,048 |
1,002 |
$15K |
| 87081 |
|
3,654 |
3,277 |
$13K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
120 |
116 |
$13K |
| 90461 |
|
684 |
652 |
$7K |
| 94760 |
|
845 |
657 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
144 |
99 |
$4K |
| 92551 |
|
1,284 |
1,210 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
450 |
412 |
$4K |
| 69210 |
|
40 |
36 |
$2K |
| 81003 |
|
678 |
596 |
$1K |
| A7015 |
Aerosol mask, used with dme nebulizer |
671 |
581 |
$930.24 |
| 85018 |
|
382 |
357 |
$836.89 |
| 99173 |
|
1,297 |
1,206 |
$407.16 |
| 99429 |
|
21 |
15 |
$100.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17 |
13 |
$95.34 |
| 36416 |
|
65 |
54 |
$20.90 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
240 |
210 |
$10.10 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
142 |
124 |
$5.19 |
| 90670 |
|
417 |
399 |
$0.00 |
| 90633 |
|
31 |
30 |
$0.00 |
| 90707 |
|
40 |
37 |
$0.00 |
| 90734 |
|
13 |
13 |
$0.00 |
| 99000 |
|
3,933 |
3,458 |
$0.00 |
| 90680 |
|
58 |
55 |
$0.00 |
| 90744 |
|
26 |
25 |
$0.00 |
| 90716 |
|
26 |
26 |
$0.00 |
| 90698 |
|
136 |
133 |
$0.00 |
| 90686 |
|
100 |
95 |
$0.00 |